Basit öğe kaydını göster

dc.contributor.authorYuksel, Atıl
dc.contributor.authorGul, Ahmet
dc.contributor.authorEsmer, Aytul Corbacioglu
dc.contributor.authorHas, Recep
dc.contributor.authorDural, Ozlem
dc.contributor.authorDEMIROREN, Tanju
dc.contributor.authorNehir, Asli
dc.contributor.authorKalelioglu, Ibrahim
dc.date.accessioned2021-03-04T09:39:57Z
dc.date.available2021-03-04T09:39:57Z
dc.date.issued2013
dc.identifier.citationEsmer A. C. , Gul A., Nehir A., Yuksel A., Dural O., Kalelioglu I., Has R., DEMIROREN T., "Detection Rate of Trisomy 21 in Fetuses with Isolated and Non-Isolated Aberrant Right Subclavian Artery", FETAL DIAGNOSIS AND THERAPY, cilt.34, sa.3, ss.140-145, 2013
dc.identifier.issn1015-3837
dc.identifier.otherav_694e2536-df54-4c78-ad48-a5c5f35eedea
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/72973
dc.identifier.urihttps://doi.org/10.1159/000354650
dc.description.abstractObjective: The purpose of this study was to determine the frequency of chromosomal anomalies among the fetuses with isolated and non-isolated aberrant right subclavian artery (ARSA), and to evaluate the sonographic findings associated with ARSA. Methods: This is a retrospective study conducted during the period between January 2008 and December 2012 at the maternal fetal medicine units of three different referral centers. Results: Among the 148 cases of ARSA, 98 were isolated and 50 were associated with cardiac anomalies, extracardiac malformations or soft markers. Trisomy 21 was the only chromosomal anomaly with a prevalence of 6.8% (10/148). The corresponding rate was 6.1% (6/98) and 8% (4/50) for isolated and non-isolated ARSA, respectively. Cardiac anomalies, extracardiac findings and soft markers were detected in 5.4% (8), 10.8% (16) and 24.3% (36) of cases, respectively. Among the 10 fetuses with trisonny 21, 6 were isolated, 4 were associated with soft markers, 2 were associated with fetal growth restriction and 1 was associated with hydrops fetalis. Cardiac anomalies were not observed in any of these fetuses. Conclusion: The prenatal diagnosis of ARSA should prompt meticulous anatomic survey, and karyotype analysis might be offered even in the absence of associated findings. Copyright (C) 2013 S. Karger AG, Basel
dc.language.isoeng
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.titleDetection Rate of Trisomy 21 in Fetuses with Isolated and Non-Isolated Aberrant Right Subclavian Artery
dc.typeMakale
dc.relation.journalFETAL DIAGNOSIS AND THERAPY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume34
dc.identifier.issue3
dc.identifier.startpage140
dc.identifier.endpage145
dc.contributor.firstauthorID4794


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster